Meridian Bioscience

Meridian Bioscience Treasury Stock

The Treasury Stock of Meridian Bioscience (VIVO) as of Oct 26, 2026 is -10.50 M USD. In the previous year, Treasury Stock was 198,000.00 USD — a change of -5,405.05% (lower).

Treasury Stock

-10.50 MUSD

YoY

-5,405.05%

Last updated:

Treasury Stock of Meridian Bioscience is 2022 -10.50 M USD. Treasury Stock of Meridian Bioscience was 2021 198,000.00 USD. It decreases by -5,405.05% lower compared to the previous year.

The Meridian Bioscience Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2015
-2.30 M USD
Jan 1, 2016
-5.50 M USD
Jan 1, 2017
-2.90 M USD
Jan 1, 2018
-3.40 M USD
Jan 1, 2019
-5.00 M USD
Jan 1, 2020
-1.90 M USD
Jan 1, 2021
198,000.00 USD
Jan 1, 2022
-10.50 M USD
The Meridian Bioscience Treasury Stock history
YEARTreasury StockYoY
-10.50 MUSD-5,405.05%
198,000.00USD-110.42%
-1.90 MUSD-62.00%
-5.00 MUSD+47.06%
-3.40 MUSD+17.24%
-2.90 MUSD-47.27%
-5.50 MUSD+139.13%
-2.30 MUSD-866.67%
300,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Treasury Stock of Meridian Bioscience is -10.50 M USD in 2022.

Treasury Stock of Meridian Bioscience changed from 198,000.00 USD to -10.50 M USD, representing a -5,405.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Meridian Bioscience

All Key Metrics — Meridian Bioscience